⌘K

Login Start Free

Home/Filings/4/0001209191-22-038677

4//SEC Filing

Byrnes Michael 4

Accession 0001209191-22-038677

CIK 0001828522other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 4:17 PM ET

Size

5.5 KB

Accession

0001209191-22-038677

Insider Transaction Report

Form 4

Period: 2022-06-20

eFFECTOR Therapeutics, Inc.EFTR

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2022-06-20+235,541→ 235,541 total
Exercise: $1.49Exp: 2032-06-19→ Common Stock (235,541 underlying)

Footnotes (1)

[F1]The stock option vests 50% on June 20, 2023, and in 12 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

eFFECTOR Therapeutics, Inc.

CIK 0001828522

Entity typeother

Related Parties

1

filerCIK 0001619893

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 4:17 PM ET
Size: 5.5 KB

View on SEC.gov